Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
Tempest Therapeutics’ Merger With Millendo Therapeutics
Tempest Therapeutics’ Merger With Millendo Therapeutics
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
IMAX Corporation’s Joint Venture With Maximus
Sidley Austin LLP advised IMAX Corporation on the joint venture with Maximus, assisted by Carey Olsen and Goodwin Procter LLP. IMAX Corporation (NYSE: IMAX) announced a joint...